ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 132 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,679 | +30.4% | 55,893 | +62.5% | 0.00% | – |
| Q2 2023 | $128,619 | +106.6% | 34,390 | +80.7% | 0.00% | – |
| Q1 2023 | $62,241 | -25.5% | 19,034 | +9.6% | 0.00% | – |
| Q4 2022 | $83,516 | -6.2% | 17,363 | +11.3% | 0.00% | – |
| Q3 2022 | $89,000 | -1.1% | 15,607 | +23.4% | 0.00% | – |
| Q2 2022 | $90,000 | -62.8% | 12,644 | -62.3% | 0.00% | – |
| Q1 2022 | $242,000 | -54.1% | 33,514 | -43.1% | 0.00% | – |
| Q4 2021 | $527,000 | -77.9% | 58,927 | -13.5% | 0.00% | -100.0% |
| Q3 2021 | $2,389,000 | – | 68,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |